Correction to: Filgotinib in Rheumatoid Arthritis: A Profile of Its Use

被引:0
|
作者
Esther S. Kim
Susan J. Keam
机构
[1] Springer Nature,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:101 / 101
相关论文
共 50 条
  • [1] Filgotinib in Rheumatoid Arthritis: A Profile of Its Use
    Esther S. Kim
    Susan J. Keam
    Clinical Drug Investigation, 2021, 41 : 741 - 749
  • [2] Filgotinib in Rheumatoid Arthritis: A Profile of Its Use
    Kim, Esther S.
    Keam, Susan J.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (08) : 741 - 749
  • [3] Filgotinib in Rheumatoid Arthritis: A Profile of Its Use (vol 41, pg 741, 2021)
    Kim, Esther S.
    Keam, Susan J.
    CLINICAL DRUG INVESTIGATION, 2022, 42 (01) : 101 - 101
  • [4] Filgotinib in rheumatoid arthritis
    Westhovens, Rene
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (02) : 135 - 144
  • [5] Filgotinib for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (03): : E174 - E174
  • [6] Upadacitinib in rheumatoid arthritis: a profile of its use
    Sean Duggan
    Susan J. Keam
    Drugs & Therapy Perspectives, 2020, 36 : 485 - 493
  • [7] Upadacitinib in rheumatoid arthritis: a profile of its use
    Duggan, Sean
    Keam, Susan J.
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (11) : 485 - 493
  • [8] Filgotinib as rheumatoid arthritis therapy
    Becciolini, A.
    Di Donato, E.
    Santilli, D.
    Lucchini, G.
    Mozzani, F.
    Riva, M.
    Ariani, A.
    DRUGS OF TODAY, 2021, 57 (09) : 543 - 550
  • [9] Safety of filgotinib in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (07): : E421 - E421
  • [10] Filgotinib for the treatment of rheumatoid arthritis
    Taylor, Peter C.
    Azeez, Maha Abdul
    Kiriakidis, Serafim
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (10) : 1181 - 1187